Stock Split History
ETFs Holding SURF »    SURF Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Surface Oncology is a clinical-stage immuno-oncology company focused on using its knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of cancer therapies. Co.'s programs targets several components of the immunosuppressive TME. NZV930 and SRF617 are antibodies inhibiting cluster of differentiation, or CD, 73 and CD39, respectively, and illustrate how Co.'s knowledge of TME biology can be utilized across programs. SRF388 is an antibody targeting interleukin 27, an immunosuppressive cytokine in the TME that is overexpressed in certain cancers. According to our Surface Oncology stock split history records, Surface Oncology has had 0 splits.
Surface Oncology stock split history picture
Surface Oncology (SURF) has 0 splits in our Surface Oncology stock split history database.

Looking at the Surface Oncology stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Surface Oncology shares, starting with a $10,000 purchase of SURF, presented on a split-history-adjusted basis factoring in the complete Surface Oncology stock split history. Surface Oncology split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/19/2018
End date: 05/17/2021
Start price/share: $13.33
End price/share: $8.46
Dividends collected/share: $0.00
Total return: -36.53%
Average Annual Total Return: -13.73%
Starting investment: $10,000.00
Ending investment: $6,345.76
Years: 3.08
Date Ratio
LM Funding America, Inc. (LMFA)
Foxby Corp. (XFXBX)
InspireMD, Inc. (NSPR)
Aviat Networks, Inc. (AVNW)
Guardion Health Sciences, Inc. (GHSI)
China SXT Pharmaceuticals, Inc. (SXTC)
VYNE Therapeutics Inc. (VYNE)
The Sherwin-Williams Company (SHW)
Horizons US Marijuana Index ETF (HMUS)
MicroSectors FANG+ ETNs due January 8, 2038 (FNGS)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Surface Oncology
Surface Oncology Insider Buying

Surface Oncology Stock Split History | | Copyright © 2013 - 2021, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.